^
Association details:
| Biomarker: | 7-gene HEV signature |
|---|---|
| Cancer: | Solid Tumor |
| Drug Class: | Immunotherapy |
| Direction: | Sensitive |
Evidence:
Source:
Title:
2346P - Spatial and quantified molecular characterization of high endothelial venule predictive of immunotherapy response
Published date:
10/16/2023
Excerpt:
A 7-gene HEV signature we identified, especially MEOX1, can be used as a new molecular marker to identify HEV in tumors, and its expression can be used to locate and quantify HEV in tumors, and help identify potential patients who could benefit from immunotherapy.